Literature DB >> 11052456

Automated oxyhemoglobin dissociation curve construction to assess sickle cell anemia therapy.

R C Young1, R E Rachal, M Del Pilar Aguinaga, B L Nelson, B C Kim, W P Winter, O Castro.   

Abstract

Oxyhemoglobin dissociation curves measure the most important function of red blood cells - the affinity for oxygen and its delivery to the tissues. This function may be deranged in sickle cell anemia and some other hemoglobinopathies. An automated oxyhemoglobin dissociation curve analyzer constructed dissociation curves in 55 patients with hemoglobinopathies and in 24 control subjects while maintaining constant temperature and pH. Sigmoid curves were converted to rectilinear ones using the Hill equation. Oxygen affinity of red cells was assessed by calculation of P50 (the PO2 at which hemoglobin is half saturated). Results revealed separation of oxyhemoglobin dissociation Hill plots according to phenotype but with wide variability. Mean oxygen affinity of fetal hemoglobin was greatest, whereas that of sickle hemoglobin was least. Other hemoglobins were intermediate. A positive correlation between decreased oxygen affinity and carboxyhemoglobin confirmed the decreased oxygen affinity of sickle hemoglobin and decreased oxygen affinity and increased diphosphoglycerate in red cells. Hill plots are less sensitive discriminators of oxygen affinity than traditional sigmoid dissociation curves and offer no particular advantage. Serial studies in a subset of three sickle cell anemia patients treated conservatively suggest automated oxyhemoglobin dissociation curves may be useful in assessment of effectiveness of newer therapies of sickle cell anemia after refinement of the method and studies of larger populations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11052456      PMCID: PMC2608524     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  17 in total

Review 1.  Bone marrow transplantation for sickle cell disease: where do we go from here?

Authors:  M C Walters
Journal:  J Pediatr Hematol Oncol       Date:  1999 Nov-Dec       Impact factor: 1.289

2.  Low pulse oximeter-measured hemoglobin oxygen saturations with hemoglobin Cheverly.

Authors:  R J Hohl; A R Sherburne; J E Feeley; T H Huisman; C P Burns
Journal:  Am J Hematol       Date:  1998-11       Impact factor: 10.047

3.  Oxyhemoglobin affinity in chronic pulmonary granulomatosis (sarcoidosis) and fibrosis.

Authors:  E B Weiss; P Slawsky; J F Desforges
Journal:  Am Rev Respir Dis       Date:  1971-11

4.  The regulation of hemoglobin affinity for oxygen in man.

Authors:  C Lenfant; J D Torrance; C A Finch
Journal:  Trans Assoc Am Physicians       Date:  1969

5.  Direct determination of 2,3-diphosphoglycerate.

Authors:  Z B Rose; J Liebowitz
Journal:  Anal Biochem       Date:  1970-05       Impact factor: 3.365

6.  Reciprocal binding of oxygen and diphosphoglycerate by human hemoglobin.

Authors:  R Benesch; R E Benesch; C I Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1968-02       Impact factor: 11.205

7.  An increased Bohr effect in sickle cell anemia.

Authors:  Y Ueda; R L Nagel; R M Bookchin
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

8.  Lung function in sickle cell hemoglobinopathy patients compared with healthy subjects.

Authors:  R C Young; R E Rachal; C A Reindorf; E M Armstrong; O D Polk; R L Hackney; R B Scott
Journal:  J Natl Med Assoc       Date:  1988-05       Impact factor: 1.798

9.  Dimethyl adipimidate: a new antisickling agent.

Authors:  B H Lubin; V Pena; W C Mentzer; E Bymun; T B Bradley; L Packer
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

10.  Inhibition of erythrocyte sickling by cystamine, a thiol reagent.

Authors:  W Hassan; Y Beuzard; J Rosa
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

View more
  8 in total

1.  Arterialization of peripheral venous blood in sickle cell disease.

Authors:  Masoud Nahavandi; Richard M Millis; Fatemeh Tavakkoli; Meville Q Wyche; Elliott Perlin; William P Winter; Oswaldo Castro
Journal:  J Natl Med Assoc       Date:  2002-05       Impact factor: 1.798

2.  Brain O2 reserve in sickle cell disease.

Authors:  John C Wood
Journal:  Blood       Date:  2019-05-30       Impact factor: 22.113

3.  Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review.

Authors:  Jane A Little; Vicki R McGowan; Gregory J Kato; Kristine S Partovi; Jordan J Feld; Irina Maric; Sabrina Martyr; James G Taylor; Roberto F Machado; Theo Heller; Oswaldo Castro; Mark T Gladwin
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

4.  The relationship of oxygen transport and cardiac index for the prevention of sickle cell crises.

Authors:  Kevin Farrell; Leon Dent; Minh Ly Nguyen; Maciej Buchowski; Ananta Bhatt; Maria del Pilar Aguinaga
Journal:  J Natl Med Assoc       Date:  2010-11       Impact factor: 1.798

5.  Bulk volume susceptibility difference between deoxyhemoglobin and oxyhemoglobin for HbA and HbS: A comparative study.

Authors:  Cihat Eldeniz; Michael M Binkley; Melanie Fields; Kristin Guilliams; Dustin K Ragan; Yasheng Chen; Jin-Moo Lee; Andria L Ford; Hongyu An
Journal:  Magn Reson Med       Date:  2021-01-21       Impact factor: 3.737

6.  Cerebral oxygen metabolic stress is increased in children with sickle cell anemia compared to anemic controls.

Authors:  Melanie E Fields; Amy E Mirro; Michael M Binkley; Kristin P Guilliams; Josiah B Lewis; Slim Fellah; Yasheng Chen; Monica L Hulbert; Hongyu An; Andria L Ford; Jin-Moo Lee
Journal:  Am J Hematol       Date:  2022-02-14       Impact factor: 13.265

7.  Oxygen carrying capacity of salvaged blood in patients undergoing off-pump coronary artery bypass grafting surgery: a prospective observational study.

Authors:  Xiu Liang Li; Peng Dong; Ming Tian; Jia Xiang Ni; Fang Gao Smith
Journal:  J Cardiothorac Surg       Date:  2015-10-14       Impact factor: 1.637

8.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.